Why does the concentration of the sublingual vaccine need to be higher than the subcutaneous one?
To clearly understand the clinical aspects involved in Why the concentration of the sublingual vaccine? This is an essential step for those seeking diagnostic certainty, lasting symptom relief, and prevention of complications. In the daily practice of Allergology and Clinical Immunology, questions related to... "Why does the concentration of the sublingual vaccine need to be higher than the subcutaneous one?" Allergy-free conditions are common among patients and their families. The goal of this page in the Brazil Allergy-Free Encyclopedia is to present a complete, accessible, and evidence-based medical analysis, detailing causes, immunological mechanisms, and safe practices.
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
Understand why sublingual vaccines require a higher concentration than subcutaneous vaccines.
A common question among patients starting allergy immunotherapy concerns the dosage differences between the routes of administration. When comparing sublingual immunotherapy with subcutaneous injection, it is noted that the concentration of allergens in the sublingual formula needs to be considerably higher. This technical requirement is based on how the body interacts with the medication in each of the application methods.
In the case of subcutaneous vaccination, absorption occurs directly, since the injection is applied to the tissues under the skin, allowing the components to be fully utilized by the immune system. On the other hand, the sublingual route faces natural barriers of the human body immediately after contact with the oral mucosa. Among the main factors that reduce direct absorption are:
- The action of enzymes present in saliva, capable of breaking down some of the proteins in allergens;
- The involuntary swallowing of part of the solution during or shortly after application;
- The loss of small amounts of the product that leak into the oral cavity before complete absorption.
To compensate for these natural losses and ensure that an adequate amount of allergen reaches the immune system to stimulate tolerance, experts adjust the formula, increasing the concentration of the allergenic extract in the sublingual presentation compared to the subcutaneous one.
In terms of clinical efficacy, sublingual vaccines have proven to be a very interesting and safe alternative for the treatment of respiratory allergies. Although the subcutaneous route still maintains the traditional standard of maximum efficacy, scientific research is continuously advancing in the development of new techniques to optimize sublingual absorption, bringing therapeutic results closer together between methods. Furthermore, alternatives such as the use of nasal vaccines for the control of allergic rhinitis also represent promising fields of study and application in medical practice.
Important note: This content is for educational and informational purposes only and does not, under any circumstances, replace consultation, diagnosis, and individualized prescription performed by a physician specializing in Allergy and Immunology.
Developments in Evidence-Based Medicine: The Unified Airway Concept (ARIA/EPOS)
The international ARIA consensuses (Allergic Rhinitis and its Impact on Asthma) and EPOS (European Position Paper on Rhinosinusitis and Nasal Polyps) consolidate the pathophysiological concept of single (unified) air routeThe nasal mucosa, paranasal sinuses, and tracheobronchial tree share the same ciliated pseudostratified respiratory epithelium and the same immunological mechanisms mediated by IgE, mast cells, and eosinophils. Persistent edema of the sinus drainage ostia in uncontrolled allergic rhinitis predisposes to mucociliary stasis, post-nasal drip, recurrent rhinosinusitis, and bronchial hyperreactivity. Evidence-based management integrates nasal hygiene with isotonic/hypertonic saline solution, topical intranasal corticosteroids, environmental control, and... allergen-specific immunotherapy to induce lasting immune tolerance.
💎 Diamond Plan — Safe immunization, even for those with a history of allergies. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Unified Airway: Management of Rhinitis, Rhinosinusitis, and Nasal Hypersensitivity
Inflammation of the Respiratory Mucosa, House Mites, and Local Complications
The nose performs vital functions of filtering, warming, and humidifying inhaled air before it reaches the lungs. In allergic rhinitis and chronic rhinosinusitis, contact between aeroallergens—especially house dust mites (Dermatophagoides pteronyssinus and Blomia tropicalis), anemophilous fungi, and epithelia—and IgE antibodies fixed to mast cells in the nasal mucosa triggers the immediate release of histamine, leukotrienes, and prostaglandins. This process generates nasal obstruction, itching, sneezing fits, post-nasal drip (a frequent cause of chronic nighttime cough), and vascular fragility that can favor minor bleeding (epistaxis) due to trauma from blowing the nose or from poorly directed sprays.
Nasal Irrigation, Safe Topical Sprays, and Desensitizing Immunotherapy
Daily nasal irrigation with isotonic saline solution mechanically removes allergens, pollutants, and inflammatory mediators, enhancing the safe topical action of prescribed sprays (always applied by directing the nozzle towards the lateral wall of the nose, away from the septum). To go beyond palliative relief, perform the... allergy test allows structuring the rhinitis treatment specialized and within your reach with allergy vaccine, the only resource capable of re-educating the immune response to respiratory allergens.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
Treating the cause of an allergy requires consistency — and consistency requires access. Diamond Plan It was designed for patients throughout Brazil who face the high cost of allergy vaccines and the difficulties of travel, offering specialized follow-up via telemedicine and easy access to immunotherapy treatment. Safe immunization, even for those with a history of allergies.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
In summary, the appropriate approach to Why the concentration of the sublingual vaccine? It requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoiding self-medication and investigating the root cause of symptoms—relying on specialized resources and reliable guidance such as specialized allergy and immunology care when clinically relevant—is the safest way to control flare-ups, prevent complications, and ensure sustainable quality of life.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




